Openbookopenbook
Equity
Quest Diagnostics Incorporated(DGX)
USD --+0.00%
Reward45Moderate
Risk38Moderate
📊75%Data
DGX
+0.0 · +0.00%
USD · NYSE
Quest Diagnostics Incorporated | Healthcare
Value Trap
Market Cap:23.31Bn
ℹ️
Reward Rating
45
Moderate
Bottom 25% (model universe)
75% data coverage
ℹ️
Risk Rating
38
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on DGX to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $217.38.

What is Quest Diagnostics Incorporated?

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally.

DGX · Verdict

Moderate reward · moderate risk

DGX stands out on cash flow and volatility, but watch the growth signal.

Based on 88% data coverage

DGX · Verdict

What’s working & what to watch

Strengths 2

  • Cash flow79/100

    12% free-cash-flow margin

  • Volatility65/100

    Above average

Watchouts 3

  • Growth38/100

    Rev +3.7% CAGR · earnings +1.6%

  • Balance sheet40/100

    Interest covered 6.0×

  • Profitability43/100

    9% net margin · 15% ROE

Model-based scoring. For information only — not financial advice.

What is Quest Diagnostics Incorporated?

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. The company is listed on the NYSE in USA, operating in the Healthcare sector, with a market capitalisation of 23.31B, and a P/E ratio of 23.9x.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Profitability metrics are mixed — margins may be under pressure.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: Moderate (45)

The scoring profile indicates limited reward potential at this time, with valuation and momentum offering the most support. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap23.31B
P/E Ratio23.9201
Dividend Yield1.54%
52 Week High213.2
52 Week Low155.0889
Last AnnualDecember
IPO Date12/17/1996
IncorporatedUSA
Shares Outstanding110M
No. of Employees57,000
IndustryDiagnostics & Research
ExchangeNYSE
Beta0.675
CurrencyUSD
Websitewww.questdiagnostics.com
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.